Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference104 articles.
1. The Multiple Sclerosis International Federation. Atlas of MS. 3rd ed. 2020.
2. Giovannoni G, Butzkueven H, Dhib-Jalbut S, Hobart J, Kobelt G, Pepper G, et al. Brain health: time matters in multiple sclerosis. Mult Scler Relat Disord. 2016;9(Suppl. 1):S5-48.
3. Mavenclad 10 mg tablets. Summary of product characteristics (SmPC). 2021. https://www.ema.europa.eu/en/documents/product-information/mavenclad-epar-product-information_en.pdf. Accessed 8 Jun 2021.
4. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17.
5. Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med. 2010;362(5):416–26.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献